Starling Oncology (STLNW) Cash & Equivalents Growth (3y) (2022 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 26.89% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 26.75% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | -5.94% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | - |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 9.04% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 266.90% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | -3.64% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | 6.90% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -46.30% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 12.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.46% |
| Mar 31, 2026 | 25.69% |
| Dec 31, 2025 | 33.81% |
| Sep 30, 2025 | -23.35% |
| Jun 30, 2025 | -22.15% |
| Mar 31, 2025 | -25.35% |
| Dec 31, 2024 | -24.45% |
| Sep 30, 2024 | 60.19% |
| Jun 30, 2024 | 33.91% |
| Mar 31, 2024 | 9.57% |
| Dec 31, 2023 | 77.40% |
| Sep 30, 2023 | 202.11% |
| Jun 30, 2023 | 196.97% |
| Dec 31, 2022 | 78.92% |